Información del artículo
Resumen
Se realiza un análisis de la situación actual de las recidivas locorregionales en el cáncer de recto, cuya incidencia se admite de forma generalizada que debe oscilar entre el 2 y el 10%.
Sólo las series que se sitúen en estos márgenes podrán contribuir con rigor al estudio de los múltiples aspectos implicados: factores de riesgo, seguimiento y diagnóstico adecuados y procedimientos terapéuticos efectivos.
Se insiste en que un diagnóstico temprano del cáncer de recto, una intervención quirúrgica correcta y la contribución del tratamiento neoadyuvante conseguirán minimizar e incluso hacer desaparecer este trascendental problema, que se considera causa de muerte en un elevado número de pacientes.
Palabras clave:
Cáncer de recto
Recidiva locorregional
We perform an analysis of the situation of locoregional recurrences after surgery for rectal carcinoma. The admitted rate must be between 2 and 10%. Only studies of series with these results can contribute to the analysis of the importance of the different factors implicated, as they are risk factors, follow up and appropriate diagnosis and effective therapeutic procedures.
We remark thagt an early diagnosis, a proper surgical operation and adjuvant therapy are necessary to reduce and even make disappear this significant problem, which is considered to be the cause of dearh in a high number of patients.
Key words:
Rectal cancer
Locoregional recurrence
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.M.D. Wheeler, B.F. Warren, N.J.Mc.C Mortensen, N. Ekanyaka, H. Kulacoglu, A.C. Jones, et al.
Quantification of histologic regression of rectal cancer after irradiation.
Dis Colon Rectum, 45 (2002), pp. 1051-1056
[2.]
K. Yamada, T. Ishizawa, K. Niwa, Y. Chuman, T. Aikon.
Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
Dis Colon Rectum, 45 (2002), pp. 1078-1084
[4.]
R.J. Heald, E.M. Husband, R.D. Ryall.
The mesorectum in rectal cancer surgery-the clue to pelvic recurrence?.
Br J Surg, 69 (1982), pp. 613-616
[5.]
P. Chapuis, L. Bokey, M. Fahrer, G. Sinclair, M. Comm, N. Bogduk.
Mobilization of the rectum. Anatomic concepts and the bookshelf revisited.
Dis Colon Rectum, 45 (2002), pp. 1-9
[6.]
C. Ratto, R. Ricci, C. Rossi, U. Morelli, F.M. Vecchio, G.B. Doglietto.
Mesorectal microfoci adversely affect the prognosis of patients with rectal cancer.
Dis Colon Rectum, 45 (2002), pp. 733-743
[7.]
C.h. Ono, K. Yoshinaga, M. Enomoto, K. Sugihare.
Discontinuous rectal cancer spread in the mesorectum and the optimal distal clearance margen in situ.
Dis Colon Rectum, 45 (2002), pp. 744-749
[8.]
T.E. Read, R.J. Myerson, J.W. Fleshman, R.D. Fry, E.H. Birnbaum, B.J. Walz, et al.
Surgeon specialty is associated with outcome in rectal cancer treatment.
Dis Colon Rectum, 45 (2002), pp. 904-914
[9.]
A. Wibe, B. Moller, J. Norstein, E. Carlsen, J.N. Wiig, R.J. Heald, et al.
A national strategic change in treatment policy for rectal cancer implementation of total mesorectal escisión as routine treatment in Norway. A national audit.
Dis Colon Rectum, 45 (2002), pp. 857-866
[10.]
M. Romero, R. Alós, J. Aparicio, R. Estevan, J. García, E. Grau, et al.
Resumen de la guía práctica clínica en el cáncer colorrectal de la Sociedad Valenciana de Cirugía.
Cir Esp, 65 (1999), pp. 326-330
[11.]
R.J. Heald, B.J. Moran, R.D. Ryall, R. Sexton, J.K. Mac Farlane.
Rectal cancer: basingstoke experience of total mesorectal excision 1978- 1992.
Arch Surg, 133 (1998), pp. 894-899
[12.]
T. Holm, H. Johansson, B. Cedermark, G. Ekelund, L.E. Rutqvist.
Influence of hospital-and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy.
Br J Surg, 84 (1997), pp. 657-663
[13.]
F. López-Kostner, V.W. Fazio, A. Vignali, L.A. Rybicki, I.C. Lavery.
Locally recurrent rectal cancer: predictors and success of salvage surgery.
Dis Colon Rectum, 44 (2001), pp. 173-178
[14.]
J. Cerdán, R. Cantero, J.A. López, P. Talavera, A. Cascón, J.L. Balibrea.
Cáncer de recto: exfoliación celular durante la disección rectal y valor del lavado peroperatorio.
Cir Esp, 64 (1998), pp. 581-583
[15.]
P. Quirke, M.T. Dixon, P. Durdey, N.S. Williams.
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection.
Lancet, 1 (1986), pp. 996-998
[16.]
G.A. Porter, C.L. Soskoline, W.W. Yakimets, S.C. Newman.
Surgeon-related factors and outcomes in rectal cancer.
Ann Surg, 227 (1998), pp. 157-167
[17.]
J. Cerdán.
Seguimiento de los pacientes intervenidos de cáncer colorrectal.
Rev Cáncer, 11 (1997), pp. 32-41
[18.]
V.A. Komborozos, G.J. Skrekas, C.A. Pissiotis.
The contribution of follow- up programs in the reduction of mortality of rectal cancer recurrences.
Dig Surg, 18 (2001), pp. 403-408
[19.]
R.J. Méndez, R. Rodríguez, T. Kovacevich, S. Martínez, G. Moreno, F.J. Cerdán.
CT in the detection of local recurrence of rectal carcinoma.
J Comput Assist Tomogr, 17 (1993), pp. 741-744
[20.]
P. Robinson, B.M. Carrington, R. Swindell, J.H. Shanks, S.T. O'Dwyer.
Recurrent or residual pelvic bowed cancer: accuracy of MRI local extent before salvage surgery.
Clin Radiol, 57 (2002), pp. 514-522
[21.]
P.A. Jr. Lucha, L. Rosen, J.A. Olenwine, J.F. Reed III, R.D. Riether, J.J. Stasik, et al.
Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorrectal carcinoma.
Dis Colon Rectum, 40 (1997), pp. 145-149
[22.]
F. Baulieu, P. Bourlier, B. Scotto, C. Mor, V. Eder, L. Picon, et al.
The value of immunoscintigraphy in the detection of recurrent colorectal cancer.
Nucl Med Commun, 22 (2001), pp. 1295-1304
[23.]
J. García-Aguilar, J.W. Cromwell, C. Marra, S.H. Lee, R.D. Madoff, D.A. Rothenberger.
Treatment of locally recurrent rectal cancer.
Dis Colon Rectum, 44 (2001), pp. 1743-1748
[24.]
G.H. Mannaerts, H.J. Rutten, H. Martijn, G.J. Groen, P.E. Hanssens, T. Wiggers.
Abdominosacral resection for primary irresectable and locally recurrent rectal cancer.
Dis Colon Rectum, 44 (2001), pp. 806-814
[25.]
H.J. Wanebo, P. Antoniuk, R.J. Koness, A. Levy, M. Vezeridis, S.I. Cohen, et al.
Pelvic resection of recurrent rectal cancer: technical considerations and outcome.
Dis Colon Rectum, 42 (1999), pp. 1438-1448
[26.]
M. Shoup, J.G. Guillem, K.M. Alektiar, K. Lian, P.B. Paty, A.M. Cohen, et al.
Predictor of survival in recurrent rectal cancer after resection and intraoperative radiotherapy.
Dis Colon Rectum, 45 (2002), pp. 585-592
[27.]
J.N. Wiig, K.M. Tveit, J.P. Poulsen, D.R. Olsen, K.E. Giercksky.
Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study.
Radiother Oncol, 62 (2002), pp. 207-213
[28.]
L.F. Williams, C.B. Huddleston, J.L. Sawyers, J.R. Potts III, K.W. Sharp, S.W. McDougal.
Is total pelvic exenteration reasonable primary treatment for rectal carcinoma.
Ann Surg, 207 (1988), pp. 670-678
[29.]
J.N. Wiig, J.P. Poulsen, S. Larsen, M. Braendengen, H. Waehre, K.E. Giercksky.
Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer.
Eur J Surg, 168 (2002), pp. 42-48
[30.]
H.S. Ketcham.
The management of recurrent rectal cancer.
Can J Surg, 28 (1985), pp. 422-424
[31.]
K. Yamada, T. Ishizawa, K. Niwa, Y. Chuman, S. Akiba, T. Aikon.
Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer.
Br J Surg, 88 (2001), pp. 988-993
[32.]
M. Mohiuddin, G. Marks, J. Marks.
Long-term results of reirradiation for patients with recurrent rectal carcinoma.
Cancer, 95 (2002), pp. 1144-1150
[33.]
P. Pacini, L. Cionini, L. Pirtoli, S. Ciatto, E. Tucci, L. Sebaste.
Syntomatic recurrences of carcinoma of the rectum and sigmoid. The influence of radiotherapy on the quality of life.
Dis Colon Rectum, 29 (1986), pp. 865-868
[34.]
G.H. Mannaerts, H.J. Rutten, H. Martijn, P.E. Hanssens, T. Wiggers.
Effects on functional outcome after IORT-containing multimodality treatment for locally advanced primary and locally recurrent rectal cancer.
Int J Radiat Oncol Biol Phys, 54 (2002), pp. 1082-1088
[35.]
C. Yárnoz, A. Sanz, L. Cuesta, M. Montes, M. De Miguel, H. Ortiz.
¿Disminuye la radioterapia la frecuencia de implantes en el mesorrecto?.
Cir Esp, 65 (1999), pp. 374-376
[36.]
N.T. Esnaola, S.B. Cantor, M.L. Johnson, A.N. Mirza, A.R. Miller, S.A. Curley, et al.
Pain and quality of life after treatment in patients with locally recurrent rectal cancer.
J Clin Oncol, 20 (2002), pp. 4361-4367
Copyright © 2003. Asociación Española de Cirujanos
